Interim report: National Registry of Possible Drug-Induced Ocular Side Effects.
Recent data concerning 1%, 2.4%, and 10% topical ocular phenylephrine, topical ocular local anesthetics, carbonic anhydrase inhibitors, diazepam, liquid high-protein diets, sodium fluoride gel, naproxen, and thiabendazole are reviewed. Clinicians are encouraged to report possible adverse drug reactions to the National Registry of Drug-Induced Ocular Side Effects, which has been moved to the Department of Ophthalmology, University of Oregon Health Sciences Center, Portland, OR 97201.
D000368:Aged; D000779:Anesthetics, Local / Q000009:adverse effects; D002257:Carbonic Anhydrase Inhibitors / Q000009:adverse effects; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D003975:Diazepam / Q000009:adverse effects; D004044:Dietary Proteins / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005128:Eye Diseases / Q000139:chemically induced*; D005260:Female; D005460:Fluorides, Topical / Q000009:adverse effects; D006801:Humans; D007223:Infant; D008875:Middle Aged; D009288:Naproxen / Q000009:adverse effects; D010656:Phenylephrine / Q000009:adverse effects; D012042:Registries; D013827:Thiabendazole / Q000009:adverse effects
D000779:Anesthetics, Local; D002257:Carbonic Anhydrase Inhibitors; D004044:Dietary Proteins; D005460:Fluorides, Topical; D010656:Phenylephrine; D009288:Naproxen; D013827:Thiabendazole; D003975:Diazepam